Company Info
Phone(650) 515-3185
Year Established
2008
Ticker
CTMX
Exchange
NASDAQ
Contacts
Sean McCarthy, D.Phil.Chair & CEO
Jeff Landau
CBO
Marcia P. Belvin, Ph.D.
CSO
Lloyd A. Rowland, Jr., J.D.
General Counsel
Yu-Waye (Wayne) Chu, M.D.
CMO
Chris Ogden
CFO
Company Description
CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody technology platform.
